天辰生物自成立以来,始终专注于自身免疫疾病领域的创新抗体药物研发,聚焦过敏与补体两大赛道。其核心产品LP-003(下一代抗IgE抗体)和LP-005(全球补体双功能抗体)凭借显著的临床优势,成为公司发展的双引擎。公司基于核心产品布局多个适应症,覆盖呼吸、皮肤、过敏、血液、肾科等疾病领域,其中4个适应症已进入II/III期临床,公司专利申请数量及临床进度均居行业前列。联合创始人孙乃超博士是奥马珠单抗的主要发明人,曾创立美国Tanox公司并推动其上市,被誉为华人抗体药物领域的“黄埔军校”。天辰生物正加速推进LP-003 过敏性鼻炎的III期临床和商业化准备,并计划拓展LP-005的多适应症开发,同时也在积极推进核心项目的海外拓展。
What does 天辰生物医药(苏州)股份有限公司 require? Who is 天辰生物 hiring? 天辰生物 recruitment: 生物/制药/化工/环保类占比最多占58.3%,其次是医疗卫生/美容保健类占37.5%. What education can get in at 天辰生物? 硕士占比最多占54.2%,其次是本科占29.2%. High education required at 天辰生物? 硕士占54.2%,博士占16.7%. Work experience required at 天辰生物? 5-10年占比最多占45.8%,其次是3-5年占29.2%. Where are the job locations at 天辰生物? 上海占比最多占91.7%,其次是沈阳占4.2%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows